Work

Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria

Year: 2017

Type: article

Source: Journal of Antimicrobial Chemotherapy

DOI: 10.1093/jac/dkx467

Authors: Yingjun Liu, Henry Pertinez, Fatima Ortega-Muro, Laura Alameda-Martin, Thomas Harrison, Geraint Davies, Anthony Coates, Yanmin Hu

Institutions: St George's, University of London, University of Liverpool, GlaxoSmithKline (Spain)

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Medical Research Council

Awards: G1405785118, Novel strategies to detect and eliminate persistent Mycobacterium tuberculosis - applications in a murine Cornell model

OpenAlex ID: W2773455398

FWCI: 2.104

Cites: 28

Cited by: 20

Related to: 10